AI & Tooling

The President of the Public Affairs Council issued a birthday letter emphasizing the importance of civic engagement and community involvement.

• Gold IRA Markets Team
• July 3, 2026

Partner Therapeutics announced the publication of eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma in the Journal of Clinical Oncology.

• Gold IRA Markets Team
• July 2, 2026

A Ramp study shows that firms spending the most on AI are also growing their employment, highlighting a link between AI investment and job creation.

• Gold IRA Markets Team
• July 1, 2026

A Ramp study reveals companies investing heavily in AI are also expanding their workforce, highlighting the link between AI spending and job growth.

• Gold IRA Markets Team
• July 1, 2026

Jeremy Grantham urges investors to exit U.S. equities before a potential major market downturn, citing AI risks and economic vulnerabilities.

• Gold IRA Markets Team
• June 26, 2026

Google faces the departure of two prominent AI icons, with the real story centered on the math behind its stock valuation and the broader implications for AI development.

• Gold IRA Markets Team
• June 23, 2026

Grupo Aeroportuario del Centro Norte benefits from Mexico hosting the World Cup, boosting its growth prospects amid a broader bullish outlook for its airports.

• Gold IRA Markets Team
• June 21, 2026

Get a 2-pack of patriotic 5-gallon buckets with lids at Sam’s Club for just $5.76 through July 5, a significant discount from the regular price.

• Gold IRA Markets Team
• June 15, 2026

Applied Materials remains too expensive to buy and too strong to sell, leaving investors in a holding pattern amid uncertain valuation and market conditions.

• Gold IRA Markets Team
• June 15, 2026

Oracle’s Q4 results show a 20x FY2027 adjusted P/E ratio, reflecting credit risks and capex uncertainties. The development raises questions about future valuation and financial stability.

• Gold IRA Markets Team
• June 15, 2026